Literature DB >> 18826370

Long-term serial passage and neuronal differentiation capability of human bone marrow mesenchymal stem cells.

Melissa L M Khoo1, Bojiang Shen, Helen Tao, David D F Ma.   

Abstract

The development of methods to induce differentiation of human mesenchymal stem cells (hMSCs) has opened the possibility of using these cells in regenerative or reparative therapies. However, the low frequency of hMSCs in tissue means it is often necessary to expand these cells extensively in vitro. In this study, we evaluated the effects of long-term serial passage on the characteristics of bone marrow-derived hMSC populations. In addition, we examined the effect on subsequent hMSC neural differentiation ability, which has not been reported earlier. The hMSC population examined was found to maintain a stable phenotype during the first 6-8 passages of culture as assessed by proliferative ability, morphological appearance, and surface antigen, gene and protein expression, and also expressed pluripotency and neural lineage markers constitutively in the undifferentiated state. Long-term subcultivation neither resulted in spontaneous neural differentiation nor compromised the ability of hMSCs to develop toward an early neuronal fate. In addition, the transformation elicited in hMSC cultures in response to cytokine-based neuronal differentiation was examined by live cell microscopy. We demonstrated, for the first time, that the observed changes result from active and dynamic processes involving outgrowth and motility of cellular extensions, processes entirely distinct from the rapid epiphenomena of cytotoxicity and cytoskeleton disruption generated by chemical induction methods. Cytokine-induced differentiation of hMSCs was also associated with upregulation of early neural gene and protein expression. These findings support the neuronal differentiation capability of hMSCs, although further investigation is required to confirm the ability to attain a mature neuronal phenotype.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18826370     DOI: 10.1089/scd.2007.0185

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  17 in total

1.  Human amniotic mesenchymal stem cell-derived induced pluripotent stem cells may generate a universal source of cardiac cells.

Authors:  Xiaohu Ge; I-Ning E Wang; Ildiko Toma; Vittorio Sebastiano; Jianwei Liu; Manish J Butte; Renee A Reijo Pera; Phillip C Yang
Journal:  Stem Cells Dev       Date:  2012-06-11       Impact factor: 3.272

2.  Sox11 is expressed in early progenitor human multipotent stromal cells and decreases with extensive expansion of the cells.

Authors:  Benjamin L Larson; Joni Ylostalo; Ryang H Lee; Carl Gregory; Darwin J Prockop
Journal:  Tissue Eng Part A       Date:  2010-07-13       Impact factor: 3.845

3.  Human amniotic membrane-derived mesenchymal stem cells labeled with superparamagnetic iron oxide nanoparticles: the effect on neuron-like differentiation in vitro.

Authors:  Guangwei Zeng; Gongping Wang; Fangxia Guan; Keliang Chang; Hongliang Jiao; Wanqin Gao; Shoumin Xi; Bo Yang
Journal:  Mol Cell Biochem       Date:  2011-05-31       Impact factor: 3.396

4.  Transplantation of predifferentiated adipose-derived stromal cells for the treatment of spinal cord injury.

Authors:  David Arboleda; Serhiy Forostyak; Pavla Jendelova; Dana Marekova; Takashi Amemori; Helena Pivonkova; Katarina Masinova; Eva Sykova
Journal:  Cell Mol Neurobiol       Date:  2011-06-01       Impact factor: 5.046

Review 5.  Mesenchymal stem cells: potential application in intervertebral disc regeneration.

Authors:  Aiqun Wei; Bojiang Shen; Lisa Williams; Ashish Diwan
Journal:  Transl Pediatr       Date:  2014-04

6.  Aging effect on neurotrophic activity of human mesenchymal stem cells.

Authors:  Maria Brohlin; Paul J Kingham; Liudmila N Novikova; Lev N Novikov; Mikael Wiberg
Journal:  PLoS One       Date:  2012-09-17       Impact factor: 3.240

7.  Transplantation of neuronal-primed human bone marrow mesenchymal stem cells in hemiparkinsonian rodents.

Authors:  Melissa L M Khoo; Helen Tao; Adrian C B Meedeniya; Alan Mackay-Sim; David D F Ma
Journal:  PLoS One       Date:  2011-05-23       Impact factor: 3.240

8.  3D porous calcium-alginate scaffolds cell culture system improved human osteoblast cell clusters for cell therapy.

Authors:  Ching-Yun Chen; Cherng-Jyh Ke; Ko-Chung Yen; Hui-Chen Hsieh; Jui-Sheng Sun; Feng-Huei Lin
Journal:  Theranostics       Date:  2015-03-01       Impact factor: 11.556

9.  Gene markers of cellular aging in human multipotent stromal cells in culture.

Authors:  Ian H Bellayr; Jennifer G Catalano; Samir Lababidi; Amy X Yang; Jessica L Lo Surdo; Steven R Bauer; Raj K Puri
Journal:  Stem Cell Res Ther       Date:  2014-04-28       Impact factor: 6.832

10.  BMP-13 emerges as a potential inhibitor of bone formation.

Authors:  Bojiang Shen; Divya Bhargav; Aiqun Wei; Lisa A Williams; Helen Tao; David D F Ma; Ashish D Diwan
Journal:  Int J Biol Sci       Date:  2009-02-13       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.